永安藥業(002365.SZ):全資子公司取得1項實用新型專利證書
格隆匯12月23日丨永安藥業(002365.SZ)公佈,公司全資子公司永安康健藥業(武漢)有限公司(以下簡稱“永安康健”)收到國家知識產權局頒發的一項實用新型專利證書,實用新型名稱:一種液體飲料滅菌設備。
本次實用新型專利的取得充分體現了永安康健在營養健康領域工藝創新與技術優勢,不斷優化公司各類功能食品生產工藝,提高產品品質,有利於公司加強專利技術保護,充分發揮自主知識產權優勢。該實用新型專利的取得暫不會對公司生產經營和業績產生重大影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.